Puma has failed in its bid for leave to appeal a decision that found its ‘Procat’ trade mark was deceptively similar to US machinery manufacturer Caterpillar’s CAT marks.
A client of Corrs Chambers Westgarth has filed an appeal after a judge found the firm went “far beyond the permissible scope” of involvement in an expert report prepared for a trade secrets case.
The conduct of Corrs Chambers Westgarth in the preparation of an ostensibly independent expert report in a trade secrets case “must not be repeated”, a judge has said, throwing out the expert’s evidence as potentially tainted by the law firm’s involvement.
An Australian designer of a trendy neoprene handbag sold at high-end department stores has lost an appeal which challenged a judge’s finding that its flagship bag was not a work of artistic craftsmanship.
The High Court has rejected a special leave application by consumer goods giant Reckitt-Benckiser in its long-running battle with the maker of painkiller Maxigesic.
The High Court has found that Novartis unit Sandoz infringed Danish drug company Lundbeck’s patent for its blockbuster antidepressant Lexapro, but has overturned a ruling that found the generic drug maker owes $26.3 million in damages.
Buy now, pay later giant Zip Co cannot rely on its infringing use of the ‘Zip’ trade mark to defend a lawsuit by the mark’s owner Firstmac, the mortgage provider’s barrister told a judge on the first day of trial in the high-stakes intellectual property dispute.
A toy designer that has been sued for allegedly copying the design of toy maker Jellycat’s beloved ‘Bashful Bunny’ has pushed back at a request for discovery concerning its design process, telling the court “a plush toy in the shape of a bunny is hardly a revolutionary concept”.
AMP has expressed optimism that it will be able to reach a settlement with DST Bluedoor in a $35.5 million lawsuit accusing it of poaching 11 DST employees after licensing the software company’s online platform.
Consumer goods giant Reckitt-Benckiser is seeking special leave from the High Court to challenge a Full Court judgment that overturned a finding that AFT Pharmaceuticals ads’ for its painkiller Maxigesic were misleading.